The story appears on

Page A3

September 8, 2009

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » World

Drug Resistance Known

CASES of resistance to Roche Holding AG's Tamiflu are likely to occur in pandemic H1N1 swine flu, in line with what has been seen in clinical trials, a Roche executive said yesterday.

Roche has said signs of resistance to Tamiflu are no surprise, given this happens also in seasonal flu. The drug netted sales of just over 1 billion Swiss francs (US$946 million) in the first half of this year.

"Isolated cases of Tamiflu-resistant pandemic H1N1 2009 are expected in line with observations from the low frequency seen in clinical studies," said Roche's David Reddy.


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend